![]() |
11th International AIDS ConferenceVancouver, British Columbia — July 7-12, 1996 |
Int Conf AIDS 1996 Jul 7-12; 11:222 (abstract no. Th.B.181)
Rodriguez JC, Mora A, Blazquez JC, Escolano CM, Royo G, Martin-Hidalgo A; Servicio de Medicina Interna, Hospital General Universitario de Elche, Spain. Fax: 96-6606108.
OBJECTIVE: To evaluate the efficacy of PCR to detect T. gondii-DNA in cerebrospinal fluid (CSF) from AIDS patients with CT.
METHODS: Retrospective study. 219 samples of CSF were analysed. Group I: 16 samples of CSF from HIV-infection patients with verified CT by finding at CAT-scan and response at treatment, 5 patients were being treated. Group II: 70 samples from immunocompetent subjects with latent toxoplasmosis infection. Group III: 70 samples from immunocompetent patients without latent toxoplasmosis infection. Group IV: 63 HIV-infected patients without CT. PCR amplifications were performed using pairs of primers designed from B1 gene of T. gondii. The reaction was carried through 40 cycles, each consisting of 60 s at 94C, 90 s at 55C and 60 s at 72C. A B1 gene oligonucleotide was used as probe. A chemiluminiscent Dot blot procedure was used to detect hybridized probe. Results were imaged on X-ray film.
RESULTS: (table: see text)
CONCLUSIONS: PCR technique provides a safe and useful method for the diagnosis of CT in HIV-infected patients. The sensitivity is better if patient is not treated yet. The assay incorporates chemiluminiscent probes that make the application of this technology feasible in clinical microbiology laboratories.
960707
ThB181
Copyright © 1996 - International AIDS Society (IAS). Reproduction of this abstract (other than one copy for personal reference) must be cleared through the IAS.